DUODART

This brand name is authorized in Austria, Australia, Cyprus, Ecuador, Spain, Finland, Hong Kong, Croatia, Israel, Nigeria, Poland, Romania, Singapore, South Africa

Active ingredients

The drug DUODART contains a combination of these active pharmaceutical ingredients (APIs):

1 Dutasteride UNII O0J6XJN02I - DUTASTERIDE

Dutasteride reduces circulating levels of dihydrotestosterone (DHT) by inhibiting both type 1 and type 2, 5α-reductase isoenzymes which are responsible for the conversion of testosterone to DHT. Read about Dutasteride

2 Tamsulosin UNII 11SV1951MR - TAMSULOSIN HYDROCHLORIDE

Tamsulosin binds selectively and competitively to post-synaptic α1-adrenoreceptors, prevailingly their subtypes designated α1A and α1D. Thus relaxation of smooth muscles of the prostate and urethra is achieved, which leads to a reduction of tonus and an improvement of the urinary flow. Read about Tamsulosin

Medication package inserts

Below package inserts are available for further reading:

Title	Information Source	Document Type
DUODART Capsule, hard	Web Search	MPI, EU: SmPC

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
G04CA52	Tamsulosin and dutasteride	G Genito urinary system and sex hormones → G04 Urologicals → G04C Drugs used in benign prostatic hypertrophy → G04CA Alpha-adrenoreceptor antagonists
Discover more medicines within G04CA52

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: AU	Pharmaceutical Benefits Scheme	Identifier(s): 10102Q, 5490Y
Country: EC	Agencia Nacional de Regulación, Control y Vigilancia Sanitaria	Identifier(s): H5100513
Country: ES	Centro de información online de medicamentos de la AEMPS	Identifier(s): 72275
Country: FI	Lääkealan turvallisuus- ja kehittämiskeskus	Identifier(s): 080023, 080034
Country: HK	Department of Health Drug Office	Identifier(s): 61184
Country: IL	מִשְׂרַד הַבְּרִיאוּת	Identifier(s): 6833
Country: NG	Registered Drug Product Database	Identifier(s): B4-3532
Country: PL	Rejestru Produktów Leczniczych	Identifier(s): 100230122, 100468920
Country: RO	Agenția Națională a Medicamentului și a Dispozitivelor Medicale	Identifier(s): W67754001, W67754002, W67754003
Country: SG	Health Sciences Authority	Identifier(s): 14181P
Country: ZA	Health Products Regulatory Authority	Identifier(s): 44/21.12/0850